عاجل
PLBelgijski sąd blokuje środki Polskiej Agencji Żeglugi Powietrznej w sporze z PfizeremTRİran'da Patlama Sesleri Duyuldu, Devrim Muhafızları ABD Üslerini Vurduğunu AçıkladıINTLU.S. NHTSA Issues Urgent Warning for 463,000 Kia Telluride SUVs Due to Fire RiskARالأنظار تتجه نحو مواجهة المغرب وفرنسا في ربع نهائي كأس العالمINTLErling Haaland fuels World Cup mind games ahead of England clashBRPolícia Civil investiga esquema de falsa venda de imóveis na Região dos LagosRUПосольство РФ в Канаде: Оттава использует спорт как инструмент политического давленияUSJudge Dismisses Lawsuit Challenging Tommy Tuberville's Alabama ResidencyARهجوم أوكراني مسير يصيب نساء في شرق روسياUSAI Training Startup Mercor Reportedly in Talks for $20 Billion Valuation RoundPLBelgijski sąd blokuje środki Polskiej Agencji Żeglugi Powietrznej w sporze z PfizeremTRİran'da Patlama Sesleri Duyuldu, Devrim Muhafızları ABD Üslerini Vurduğunu AçıkladıINTLU.S. NHTSA Issues Urgent Warning for 463,000 Kia Telluride SUVs Due to Fire RiskARالأنظار تتجه نحو مواجهة المغرب وفرنسا في ربع نهائي كأس العالمINTLErling Haaland fuels World Cup mind games ahead of England clashBRPolícia Civil investiga esquema de falsa venda de imóveis na Região dos LagosRUПосольство РФ в Канаде: Оттава использует спорт как инструмент политического давленияUSJudge Dismisses Lawsuit Challenging Tommy Tuberville's Alabama ResidencyARهجوم أوكراني مسير يصيب نساء في شرق روسياUSAI Training Startup Mercor Reportedly in Talks for $20 Billion Valuation Round
Newsgather
BackBristol Myers Squibb Partners with China's Hengrui Pharma in Multi-Billion Dollar Deal
Bristol Myers Squibb Partners with China's Hengrui Pharma in Multi-Billion Dollar Deal
خبر
CNBC15.05.2026Business

Bristol Myers Squibb Partners with China's Hengrui Pharma in Multi-Billion Dollar Deal

نظرة سريعة

Bristol Myers Squibb partners with Hengrui Pharma to develop 12 experimental drugs, marking a significant, reciprocal collaboration that could signal increased U.S. pharmaceutical development in China for faster, cheaper drug creation.

ملخص مُنشأ بالذكاء الاصطناعي

حجم الخط

Bristol Myers Squibb partners with Hengrui Pharma to develop 12 experimental drugs, marking a significant, reciprocal collaboration that could signal increased U.S. pharmaceutical development in China for faster, cheaper drug creation.

Read the full article on CNBC

مواضيع ذات صلة

This article was originally published by CNBC.

أخبار ذات صلة

المزيد حول هذا الموضوعBristol Myers Squibb